B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Cees G M Kallenberg, Thomas Hauser

Abstract

Until recently, standard of care for patients with generalized or severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has consisted of an induction regimen with cyclophosphamide (CYC) and corticosteroids followed by maintenance treatment with azathioprine. This regimen is associated with significant toxicity resulting in considerable morbidity and mortality whereas relapses are still not infrequent. In two controlled trials, the Rituximab in ANCA-associated Vasculitis study (RAVE) and the RITUXVAS trial of the European Vasculitis Study Group (EUVAS), rituximab (RTX) proved non-inferior to CYC for induction of remission. In addition, outcome at 18 months for the RAVE trial and 12 months for the RITUXVAS trial showed that RTX without maintenance treatment was as efficacious as CYC followed by azathioprine maintenance. To prevent relapses, which occur particularly in patients positive for PR3-ANCA, 500 mg RTX given every 6 months was shown to be superior to azathioprine in a French study. Thus, RTX is a new and promising therapeutic armamentarium for AAV although long-term safety has still to be established.

References

Mar 15, 1992·Annals of Internal Medicine·G S HoffmanA S Fauci
Jul 26, 1990·The New England Journal of Medicine·P W MathiesonH Waldmann
Nov 4, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Priya J Bansal, Mary C Tobin
Sep 6, 2005·Arthritis and Rheumatism·Cees G M Kallenberg
Oct 15, 2005·American Journal of Respiratory and Critical Care Medicine·Karina A KeoghUlrich Specks
May 30, 2009·Arthritis and Rheumatism·Annelies E BerdenIngeborg M Bajema
Jun 11, 2009·Best Practice & Research. Clinical Rheumatology·Jennifer Turnbull, Lorraine Harper
May 26, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Eugene P RheeJohn L Niles
Jul 22, 2010·The New England Journal of Medicine·Rachel B JonesUNKNOWN European Vasculitis Study Group
Jul 22, 2010·The New England Journal of Medicine·John H StoneUNKNOWN RAVE-ITN Research Group
Sep 13, 2011·The Journal of Allergy and Clinical Immunology·Mark D PescovitzUNKNOWN Type 1 Diabetes TrialNet Study Group
Sep 29, 2011·Arthritis and Rheumatism·Michael WalshUNKNOWN European Vasculitis Study Group
Jul 20, 2012·The New England Journal of Medicine·Paul A LyonsKenneth G C Smith
Nov 14, 2012·Nature Reviews. Rheumatology·Raashid Luqmani
Jan 1, 2013·Current Opinion in Biotechnology·Susann Müller, Karsten Hiller
Jul 3, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Cees G M KallenbergPeter Heeringa
Aug 2, 2013·The New England Journal of Medicine·Ulrich SpecksUNKNOWN RAVE-ITN Research Group
Nov 6, 2013·Nature Reviews. Nephrology·Ulf SchönermarckKirsten de Groot
Dec 11, 2013·Annals of the Rheumatic Diseases·Carol A LangfordUNKNOWN Vasculitis Clinical Research Consortium
Mar 13, 2014·Nature Reviews. Rheumatology·Fabien B VincentFabienne Mackay
Nov 6, 2014·The New England Journal of Medicine·Loïc GuillevinUNKNOWN French Vasculitis Study Group

❮ Previous
Next ❯

Citations

Jan 5, 2018·BMJ Case Reports·David Owen ReesDavid Andrew Glover

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.